|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.0800 - 1.1025|
|52 Week Range||0.8500 - 4.4400|
|Beta (3Y Monthly)||2.94|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec 16, 2019 - Dec 20, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Know Labs, Inc. (KNWN) – a creator and provider of diagnostic solutions, announced today that Larry K. Ellingson has joined its Medical, Scientific and Regulatory Advisory Board. The Advisory Board was formed to provide counsel and guidance to the Company and its senior management as they work toward FDA approval of their non-invasive UBAND Continuous Glucose Monitor. The Advisory Board is chaired by Know Labs Chief Medical Officer, James (Andy) Anderson, M.D.
Know Labs, Inc. (KNWN) a provider of diagnostic solutions, today announced Racer Technology Pte. Ltd. will manufacture its wearable UBAND Calorie Counter and later its wearable UBAND Continuous Glucose Monitor (CGM). Racer Technology, a medical device and wearables manufacturer, is headquartered in Singapore with factories across Asia. Racer Technology, led by CEO, Willy Koh, has state of the art manufacturing processes and a workforce trained in the latest manufacturing techniques.
Know Labs, Inc. (KNWN) – a creator and provider of diagnostic solutions, announced today the formation of its Medical, Scientific and Regulatory Advisory Board, the initial members of the Advisory Board and its first meeting. The Advisory Board was formed to provide counsel and guidance to the Company and its senior management, CEO Phil Bosua and Chairman and Founder, Ron Erickson. The Advisory Board is chaired by Know Labs Chief Medical Officer, James (Andy) Anderson, M.D.
Know Labs, Inc. (KNWN) a provider of diagnostic solutions, announced today that Mark Tapsak, Ph.D. has joined the Company as Vice President, Intellectual Property. In addition to Dr. Tapsak’s focus on intellectual property at Know Labs he will work to support the product development, manufacturing and launch of the Company’s UBAND Calorie Counter wearable and help drive toward FDA approval of the Company’s non-invasive UBAND Continuous Glucose Monitor. At Dexcom, a multi-billion dollar provider of continuous glucose monitoring (CGM) systems, Dr. Tapsak was the 12th employee.
Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video presentation of its Bio-RFID™ platform technology’s successful identification of blood alcohol levels. In the video presentation, CEO Phil Bosua not only discusses the Company’s use of Bio-RFID to detect blood alcohol levels, but the broad implications for its technology platform. “Over the last month we’ve been powering through a ton of experiments and innovations and are really happy to report we’ve now got an AI based algorithm that allows our technology to detect blood alcohol levels non-invasively.
Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a white paper detailing the results of an experiment using their Bio-RFID™ technology to detect varying blood-glucose levels in the human body. The experiment utilized a tissue phantom mimicking a blood/skin/muscle ratio of approximately 5%/10%/85% respectively to measure varying amounts of glucose in the blood. The experiment produced successful results with the sensor system showing strong signal response and linearity between the varying glucose levels.